No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

byKathleen Lau

May 26, 2022

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

Wellness Check: Sleep

RelatedReports

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Cardiology

Polycythemia is not associated with increased mortality in heart failure

April 28, 2026

Development of a risk index for colorectal cancer screening

Weekly Rewinds

2 Minute Medicine Rewind April 27, 2026

April 27, 2026

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Chronic Disease

Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma

February 19, 2026

Non-invasive prenatal testing linked to decreased diagnostic testing

Chronic Disease

Ruxolitinib improves symptoms in patients with disabling pansclerotic morphea

June 23, 2023

Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

Parental cannabis use increasing, cigarette use decreasing

Medical cannabis provides little improvement to sleep in chronic pain patients

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

Polycythemia is not associated with increased mortality in heart failure

2 Minute Medicine Rewind April 27, 2026

Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma

Wellness Check: Sleep

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

RelatedReports

Polycythemia is not associated with increased mortality in heart failure

2 Minute Medicine Rewind April 27, 2026

Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma

Ruxolitinib improves symptoms in patients with disabling pansclerotic morphea

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

Medical cannabis provides little improvement to sleep in chronic pain patients

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits

#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

RELATED REPORTS

Wellness Check: Sleep

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

RelatedReports

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits